Your browser doesn't support javascript.
Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic.
González-López, María Del Carmen; Díaz-Calvo, Virginia; Ruíz-González, Carlos; Nievas-Soriano, Bruno José; Rebollo-Lavado, Belén; Parrón-Carreño, Tesifón.
  • González-López MDC; Primary Health Care District of Almeria, Andalusian Health Service, 04006 Almeria, Spain.
  • Díaz-Calvo V; Primary Health Care District of Almeria, Andalusian Health Service, 04006 Almeria, Spain.
  • Ruíz-González C; Primary Health Care District of Almeria, Andalusian Health Service, 04006 Almeria, Spain.
  • Nievas-Soriano BJ; Department of Nursing Science, Physiotherapy and Medicine, University of Almería, 04006 Almeria, Spain.
  • Rebollo-Lavado B; Neurology Department, Badajoz Universitary Hospital, 06080 Badajoz, Spain.
  • Parrón-Carreño T; Department of Nursing Science, Physiotherapy and Medicine, University of Almería, 04006 Almeria, Spain.
Int J Environ Res Public Health ; 19(8)2022 04 14.
Article in English | MEDLINE | ID: covidwho-1792719
ABSTRACT

BACKGROUND:

The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consumption in vulnerable population groups.

METHODS:

A cross-sectional observational study was performed in a primary health district of Spain. The data were obtained from the Andalusian Public Health System database, for the pre-COVID-19 period, from March 2019 to February 2020, and for the COVID-19 period, from March 2020 to February 2021. Univariant and bivariant analyses were performed. The effect size was measured using the Rosenthal test.

RESULTS:

While the total number of medical prescriptions decreased by 2.5% in the COVID-19 period, the prescriptions of psychiatric drugs increased by 6.1%. The increase in the dose consumption per 1000 inhabitants (DHD) was highest for anxiolytics (7.2%), followed by hypnotic-sedatives (5.6%) and antidepressants (3.7%). The consumption of antidepressants, anxiolytics, and sedative-hypnotic drugs was higher in women, older people, and rural areas and lower in areas with social transformation needs, with these differences being statistically significant.

CONCLUSIONS:

The consumption of psychiatric drugs has increased over the COVID-19 pandemic, especially in women, older people, and rural areas. Thus, we should reflect on the adequate use of these drugs.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Anxiety Agents / COVID-19 / COVID-19 Drug Treatment Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Aged / Female / Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph19084782

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Anti-Anxiety Agents / COVID-19 / COVID-19 Drug Treatment Type of study: Experimental Studies / Observational study / Prognostic study / Randomized controlled trials Limits: Aged / Female / Humans Language: English Year: 2022 Document Type: Article Affiliation country: Ijerph19084782